In November, India's drug regulator approved the use of iNCOVACC as a heterologous booster dose - a booster for people who had previously received two doses of Covishied or Covaxin, the two main Indian vaccines - in emergency situations among adults.In December, it was approved by the drug regulator as a primary vaccine and as a subsequent booster shot in adults.
